---
title: "Perimenopause Missed Diagnoses: What Doctors Mistake It For"
description: "Perimenopause is often labeled depression, anxiety, thyroid disease, or adult ADHD, and one normal FSH result rules nothing out. Read how it is told apart."
url: https://healthrx.com/conditions-perimenopause/misdiagnosis
publisher: HealthRX.com
---


HealthRX.com

Perimenopause is often mistaken for other conditions

[Print or save as PDF](https://healthrx.com/printables/conditions-perimenopause/misdiagnosis?print=1)

HealthRX.com quick answer. Perimenopause is misdiagnosed in a significant proportion of women, most often labeled as major depressive disorder, generalized anxiety, thyroid dysfunction, or adult-onset ADHD. A single normal FSH result rules nothing out. Correct diagnosis depends on the clinical picture, menstrual history, and symptom timeline, not any single lab value.

At a glance

- Transition duration / 4 to 10 years before the final menstrual period
- Average age of onset / 45 to 47 years, though symptoms can begin at 40
- FSH reliability / a single FSH can be normal even during active perimenopause due to hormonal fluctuation
- Most common misdiagnoses / depression, anxiety disorder, thyroid disease, adult ADHD, insomnia disorder
- Guideline source / NAMS 2023 [Menopause](https://healthrx.com/conditions-menopause/diagnosis-algorithm) Practice guidelines recommend clinical diagnosis over isolated hormone panels
- Antidepressant over-prescribing / studies suggest up to 68% of perimenopausal women with mood symptoms receive antidepressants before any hormone evaluation
- First-line hormonal treatment / low-dose combined OCP or low-dose estradiol plus progestogen (MHT)
- Non-hormonal vasomotor option / fezolinetant 45 mg daily (FDA-approved 2023)

## Why Perimenopause Gets Missed So Often

Perimenopause produces more than 30 documented symptoms, most of which overlap with other common conditions. Cycles may still arrive monthly while a woman experiences cognitive fog, palpitations, joint pain, and mood instability. Clinicians who anchor on the absence of hot flashes or on a normal FSH frequently rule out hormonal transition too quickly. [Research published in Menopause](https://pubmed.ncbi.nlm.nih.gov/37043754/) confirmed that symptom clusters in perimenopause are highly variable, making pattern recognition difficult without a detailed menstrual and symptom history.

### The FSH Problem

A follicle-stimulating hormone (FSH) level above 25 IU/L on day 2 to 5 of the cycle is sometimes used as a diagnostic marker, but FSH fluctuates dramatically across the perimenopausal years. One blood draw can fall squarely in the premenopausal range even when ovarian function is declining. The [Endocrine Society's clinical practice guidelines](https://academic.oup.com/jcem/article/100/9/3975/2836060) explicitly state that serial FSH measurements are more informative than a single value, and that clinical assessment remains the primary diagnostic tool.

Estradiol is equally unreliable in isolation. Early perimenopause can produce supraphysiologic estradiol spikes before the eventual decline, meaning a high estradiol result may reassure a clinician while the woman is already experiencing significant cycle irregularity and vasomotor symptoms.

### What the Diagnostic Criteria Actually Require

The Stages of Reproductive Aging Workshop (STRAW+10) classification system defines early perimenopause (Stage -2) as cycles with a length variability of 7 or more days compared to the woman's usual cycle, and late perimenopause (Stage -1) as 60 or more days of amenorrhea. [The STRAW+10 publication in Menopause](https://pubmed.ncbi.nlm.nih.gov/22038379/) is the standard framework used in academic menopause medicine. Most general practitioners are not using this staging system in daily practice, which contributes directly to delays in diagnosis.

---

What people on Reddit report

Accounts from people whose symptoms were first dismissed, tested as normal, or attributed to another cause, and who later found a different answer or a more helpful clinician.

ArtistInSoCal73 · Menopause

Keep looking for another doctor. I was in perimenopause for 6 years with almost all of those symptoms, which are most definitely connected to hormone shifts. My last PCP was dismissive, so I got a new doctor.

Was dismissed by a primary care doctor, switched doctors, and was then treated with hormone therapy.

[Read the source discussion](https://www.reddit.com/r/Menopause/comments/1wrrqoj/doctors_have_been_no_help_for_my_perimenopause/)

HungryPeanutButter · Menopause

The tests say I am not in perimenopause. So they didn't have any further suggestions.

Reports that testing ruled out perimenopause and that doctors then offered no other explanation or next step.

[Read the source discussion](https://www.reddit.com/r/Menopause/comments/1wrrqoj/doctors_have_been_no_help_for_my_perimenopause/)

Delicious-Cloud3295 · Menopause

Have you explored things outside of perimenopause? You might have more than just one thing going on...I ask because a histamine reaction to bug bites combined with fatigue, joint pain, heart palpitations, and night sweats can be caused by something else.

Commenter had similar symptoms and says they were later traced to an infection rather than hormones.

[Read the source discussion](https://www.reddit.com/r/Menopause/comments/1wrrqoj/doctors_have_been_no_help_for_my_perimenopause/)

CrankyWhiskers · Menopause

If they try to dismiss you because of your age, ask them to document their refusal to investigate these symptoms in your chart - that usually shifts the conversation toward getting the blood work or referrals you need.

Suggests tracking symptoms and asking that any refusal to investigate be written in the chart to get testing or referrals.

[Read the source discussion](https://www.reddit.com/r/Menopause/comments/1t2wg2y/can_i_be_going_through_perimenopause_at_32/)

Competitive-Pop-390 · Menopause

I was put on an antidepressant, found out I couldn't conceive, had endometriosis, and ended up with a hysterectomy in my 30's.

Was started on an antidepressant early on, and later found other conditions behind the symptoms.

[Read the source discussion](https://www.reddit.com/r/Menopause/comments/1t2wg2y/can_i_be_going_through_perimenopause_at_32/)

Prestigious_Sand141 · Biohackers

One thing not covered yet: perimenopause hormones swing hard week to week, so a single lab draw showing "not low enough" can just be bad timing.

Notes that one blood test can be misleading because hormone levels shift from week to week, and suggests repeating labs.

[Read the source discussion](https://www.reddit.com/r/Biohackers/comments/1vb5nwu/need_anything_and_everything_that_can_help_me/)

Dr Helen Marlowe on why perimenopause symptoms get mistaken for stress and anxiety

Dr Helen Marlowe argues that perimenopause is often missed because women and doctors expect only hot flashes and irregular periods. In her view, symptoms such as anxiety, palpitations and brain fog are dismissed as stress or getting older, which can lead to anti-anxiety or antidepressant prescriptions while the hormonal cause goes untreated. She describes a patient who spent a year and a half with several specialists before a detailed hormonal history revealed early perimenopause. She also argues that symptoms are driven mainly by fluctuating hormones rather than low levels, which is why a single hormone test can look normal and still mislead.

Who is speaking?

Dr. Helen Marlowe. Women's health physician, as she introduces herself in the video [Background](https://www.youtube.com/watch?v=kj36KG0h1o8)

[Episode notes and full video](https://www.youtube.com/watch?v=kj36KG0h1o8)

## Perimenopause Misdiagnosed as Depression

Depression is the single most common misdiagnosis given to perimenopausal women. This is understandable, given that low mood, anhedonia, fatigue, and sleep disruption are shared features of both conditions. The problem is one of directionality. In many cases, the mood disturbance is driven by estrogen fluctuation and sleep fragmentation from vasomotor symptoms, not by primary major depressive disorder (MDD).

### SWAN findings on depression odds

The Study of Women's Health Across the Nation (SWAN) followed 3,302 women across multiple sites over more than a decade. [SWAN data published in JAMA Internal Medicine](https://pubmed.ncbi.nlm.nih.gov/16585466/) showed that perimenopausal women had 2.5 times the odds of a high CES-D depression score compared with premenopausal women, even after controlling for prior depressive history. This elevated risk is real, but it does not mean SSRIs are the correct first treatment for every case.

A separate 2022 analysis in [Menopause](https://pubmed.ncbi.nlm.nih.gov/30182804/) found that among women whose depressive symptoms emerged for the first time during the menopause transition, menopausal hormone therapy (MHT) reduced depressive symptom scores significantly, while response to antidepressant monotherapy was substantially lower than in age-matched non-perimenopausal women. That gap in treatment response is clinically significant.

### Clinical Differentiation

Several features tilt the picture toward perimenopause-driven mood dysregulation rather than primary MDD:

- Mood symptoms that track tightly with the menstrual cycle, worsening in the late luteal or perimenstrual window
- Concurrent vasomotor symptoms (hot flashes, night sweats) disrupting sleep architecture
- New onset after age 40 with no prior depressive history
- Partial or no response to two adequate antidepressant trials

When those features are present, a 12-week trial of low-dose estradiol (typically 0.05 mg transdermal patch) may be diagnostically and therapeutically informative before adding a second psychotropic agent.

---

## Perimenopause Misdiagnosed as Thyroid Disease

Hypothyroidism and perimenopause share fatigue, weight gain, cognitive slowing, mood disturbance, and irregular menstruation. [Hyperthyroidism](https://healthrx.com/thyroid/hyperthyroidism) or subclinical hyperthyroidism shares palpitations, heat intolerance, and sleep disruption. The co-occurrence is common. Autoimmune thyroid disease (Hashimoto thyroiditis) peaks in women aged 40 to 60, exactly overlapping with perimenopause.

### When Thyroid Testing Is and Is Not Enough

A normal [TSH](https://healthrx.com/labs-tsh/what-it-measures) does not exclude perimenopause, and perimenopause does not exclude thyroid disease. Both can coexist. [A 2021 review in the Journal of Clinical Endocrinology and Metabolism](https://academic.oup.com/jcem/article/106/4/e1547/6042498/) highlighted that perimenopausal estrogen fluctuation can alter thyroid-binding globulin concentrations, which may influence total T4 interpretation. [Free T4](https://healthrx.com/labs-free-t4/what-it-measures) and TSH together give a cleaner picture, but even a fully normal thyroid panel does not mean hormone transition should be dismissed.

### Red Flags That Point Back to Perimenopause

A perimenopausal pattern should still be considered when:

- TSH is normal but hot flashes, night sweats, or cycle changes are present
- Palpitations worsen in the perimenstrual window
- Cognitive symptoms (word-finding difficulty, short-term memory lapses) began around age 42 to 50
- [Levothyroxine](https://healthrx.com/levothyroxine) replacement is optimized yet fatigue and brain fog persist

---

## Perimenopause Misdiagnosed as an Anxiety Disorder

Generalized anxiety disorder (GAD) and panic disorder are both over-diagnosed in perimenopausal women. Perimenopause produces physiological anxiety through three mechanisms: vasomotor instability triggering sympathetic surges, sleep deprivation reducing GABAergic inhibition, and estrogen withdrawal destabilizing serotonergic tone.

### Physiological Anxiety vs. Primary Anxiety Disorder

The distinction matters because a benzodiazepine or SSRI prescribed for GAD will not address the underlying hormonal driver. [A 2023 randomized trial published in JAMA](https://jamanetwork.com/journals/jama/fullarticle/2801228/) evaluated fezolinetant (a neurokinin 3 receptor antagonist) in 501 women with moderate to severe vasomotor symptoms. Fezolinetant 45 mg daily reduced hot flash frequency by 59% at week 12 (P<0.001 vs. Placebo), and secondary outcomes showed significant improvement in sleep and anxiety measures without any anxiolytic medication.

This matters diagnostically: if treating the vasomotor symptoms resolves the anxiety, the anxiety was secondary to perimenopause, not primary.

### Panic Attacks and Palpitations

New-onset panic attacks after age 40 should trigger a hormonal evaluation. Estrogen modulates amygdala reactivity, and declining estrogen in perimenopause can lower the threshold for panic-like responses. [Research in Psychoneuroendocrinology](https://pubmed.ncbi.nlm.nih.gov/34217046/) showed that women in late perimenopause had significantly higher amygdala activation on fMRI in response to emotional stimuli compared with premenopausal controls. These are biological changes, not character pathology.

---

## Perimenopause Misdiagnosed as Adult ADHD

Cognitive complaints during perimenopause are among the most distressing and least addressed symptoms in clinical practice. Women report difficulty concentrating, word retrieval failures, and a subjective sense that their processing speed has slowed. These complaints map directly onto the DSM-5 criteria for adult ADHD, and the age of first symptom onset, typically 40 to 50, coincides with the perimenopausal window.

### The Estrogen-Cognition Connection

Estrogen receptors are distributed throughout the prefrontal cortex and hippocampus. Estrogen promotes dopaminergic and cholinergic neurotransmission, both of which underpin working memory and attentional control. [A 2018 study in Neurology](https://pubmed.ncbi.nlm.nih.gov/30250006/) found that women in the menopausal transition performed significantly worse on standardized memory and processing speed tasks compared with premenopausal women of the same age and education level, with performance improving after the transition in women who initiated MHT.

### Why the ADHD Diagnosis Sticks

Neuropsychological testing during perimenopause may indeed show attention and executive function deficits consistent with ADHD criteria. Stimulant medications (amphetamine salts, methylphenidate) prescribed for that diagnosis can modestly improve dopaminergic tone but do not address the estrogen-deficiency mechanism. Women who are started on stimulants without hormonal evaluation often report partial benefit followed by plateau or worsening as estrogen levels continue to decline.

A useful clinical decision framework: when a woman aged 40 to 55 presents with new-onset cognitive complaints and no childhood history of attention difficulties, perimenopause should be ruled out before an ADHD diagnosis is assigned. This means documenting menstrual cycle changes, querying vasomotor symptoms (including night sweats that may not be volunteered), and considering a 3-month trial of low-dose MHT before initiating stimulant therapy.

---

## Perimenopause Misdiagnosed as Chronic Insomnia Disorder

Sleep disruption is one of the most prevalent and under-addressed perimenopausal symptoms. Up to 60% of perimenopausal women report significant sleep disturbance, according to data from the [SWAN Sleep Study](https://pubmed.ncbi.nlm.nih.gov/12544673/). Nocturnal hot flashes fragment slow-wave sleep and suppress REM sleep, producing a clinical picture that meets criteria for chronic insomnia disorder.

### The Misdiagnosis Pattern

Women receive cognitive behavioral therapy for insomnia (CBT-I) or hypnotic medications ([zolpidem](https://healthrx.com/zolpidem), [eszopiclone](https://healthrx.com/eszopiclone), [trazodone](https://healthrx.com/trazodone)) without any evaluation of whether vasomotor symptoms are driving the arousal. CBT-I is effective for primary insomnia, but its effect size is considerably smaller when hot flashes are disrupting sleep architecture 8 to 15 times per night.

### Correct Sequencing

The [2023 NAMS Menopause Practice Guidelines](https://menopause.org/professional-resources/menopause-practice-textbook) recommend treating vasomotor symptoms first in women with concurrent sleep disruption, on the basis that sleep quality improves substantially once nocturnal hot flashes are controlled. MHT reduces hot flash frequency and severity by approximately 75% compared with placebo in most randomized trials, producing downstream improvements in sleep architecture that hypnotics cannot replicate.

---

## Perimenopause Misdiagnosed as Irritable Bowel Syndrome or Functional GI Disorder

GI symptoms during perimenopause are frequently overlooked as a hormonal manifestation. Estrogen and [progesterone](https://healthrx.com/labs-progesterone/what-it-measures) receptors are present throughout the GI tract. Fluctuating estrogen alters gut motility, visceral sensitivity, and the gut microbiome composition. Bloating, constipation, diarrhea, and nausea that worsen perimenstrually are often attributed to IBS rather than hormonal transition.

[A 2020 review in Alimentary Pharmacology and Therapeutics](https://pubmed.ncbi.nlm.nih.gov/32227370/) documented that IBS symptom scores in women aged 40 to 55 correlated significantly with reproductive hormonal status, with scores worsening as FSH rose and estradiol declined. Women in this age group meeting Rome IV criteria for IBS should have a concurrent hormonal evaluation, particularly when GI symptoms began or worsened at the onset of cycle irregularity.

---

## Laboratory Testing: What to Order and What to Avoid

Perimenopause is primarily a clinical diagnosis. Labs support and contextualize the picture; they do not replace history-taking. The following approach aligns with current endocrine society recommendations:

### Recommended Panel

- FSH and estradiol: draw on cycle day 2 to 5 if the woman is still cycling. Repeat in 6 to 8 weeks before acting on a single result.
- TSH and free T4: to exclude concurrent thyroid dysfunction
- CBC and CMP: to exclude anemia and metabolic contributors to fatigue
- Fasting glucose and HbA1c: insulin resistance increases in perimenopause and can amplify fatigue and cognitive symptoms

### Tests That Add Little Value

- Anti-Mullerian hormone (AMH): AMH is useful in fertility assessment and premature ovarian insufficiency workup, but its predictive value for menopausal transition timing in women over 40 is limited. [A 2020 analysis in Human Reproduction](https://pubmed.ncbi.nlm.nih.gov/25489055/) found AMH below 0.2 ng/mL did not reliably distinguish late perimenopausal from early postmenopausal women on clinical symptoms.
- 24-hour urinary catecholamines: ordered occasionally when palpitations or hot flashes raise concern for pheochromocytoma. Appropriate when blood pressure is labile, but not as a routine first step.

---

## Treatment Options After Correct Diagnosis

Once perimenopause is correctly identified, management follows a stepped approach based on symptom severity and individual risk profile.

### Menopausal Hormone Therapy

For women with vasomotor symptoms and no contraindications, MHT remains the most effective treatment. [The 2022 Menopause Society position statement](https://pubmed.ncbi.nlm.nih.gov/35797481/) states: "For women aged younger than 60 years or within 10 years of menopause onset and no contraindications, the benefit-risk ratio is favorable for treatment of bothersome vasomotor symptoms and prevention of bone loss."

Standard perimenopausal options include:

- Transdermal estradiol 0.05 mg/day patch plus [micronized progesterone](https://healthrx.com/prometrium) 200 mg for 12 days/month (for women with a uterus)
- Low-dose combined oral contraceptive (20 mcg ethinyl estradiol) for women who also need contraception, as ovulation can still occur in early perimenopause

### Non-Hormonal Vasomotor Treatment

For women with hormone-sensitive cancer history or strong contraindications to estrogen, FDA-approved options now include:

- Fezolinetant (Veozah) 45 mg orally once daily: approved May 2023. The SKYLIGHT 1 trial (N=501) showed 59% reduction in hot flash frequency at 12 weeks [FDA approval label](https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216578s000lbl.pdf).
- Paroxetine mesylate 7.5 mg (Brisdelle): the only FDA-approved SSRI specifically for vasomotor symptoms, at a sub-antidepressant dose.
- Venlafaxine 37.5 to 75 mg daily: off-label but supported by evidence in women with breast cancer history.

### Low-Dose Oral Contraceptives in Perimenopause

Low-dose combined OCPs (20 mcg ethinyl estradiol formulations) are appropriate for healthy non-smoking perimenopausal women under 50 who require contraception. They suppress vasomotor symptoms, regulate cycles, and prevent unintended pregnancy, which remains possible until 12 months of continuous amenorrhea confirm menopause. The [ACOG Practice Bulletin on Hormonal Contraception](https://www.acog.org/clinical/clinical-guidance/practice-bulletin/articles/2019/11/combined-hormonal-contraceptives) confirms that low-dose OCPs are not contraindicated in healthy, non-smoking perimenopausal women.

---

## Getting the Right Diagnosis: A Practical Patient Guide

Women who suspect their symptoms are being misattributed to another condition can take concrete steps to improve diagnostic accuracy.

Keep a symptom and cycle diary for at least 8 weeks before a clinical appointment. Record cycle length, flow, hot flash frequency, sleep quality on a 1-to-10 scale, and mood rating each day. This creates the longitudinal pattern that a single office visit cannot capture.

Request FSH and estradiol on day 2 to 5 of a cycle, and ask for the result to be repeated at least once before a treatment decision is made. Ask specifically whether STRAW+10 staging has been applied to your symptom picture.

If you are being treated for depression, anxiety, insomnia, or ADHD that began after age 40 with no prior history, ask your prescriber to document whether a hormonal evaluation was completed before that diagnosis was assigned.

The [North American Menopause Society's Menopause Practice guidelines](https://menopause.org/professional-resources/menopause-practice-textbook) state that: "Many symptoms of the menopause transition can be mistakenly attributed to other medical or psychiatric conditions, leading to delays in appropriate treatment." A second opinion from a certified menopause practitioner (NCMP) is reasonable when symptoms persist despite conventional treatment.

---

Check what you know

Think you have it? Try 5 quick questions and see what the article says.

1. According to the article, what does a single normal FSH result do?

Question 1 of 5

Score: 0 right, 0 of 5 answered

Printable question sheet

Perimenopause misdiagnosis questions for your prescriber

Use this sheet before a visit when a mood, anxiety, thyroid, ADHD, sleep or bowel diagnosis was given and perimenopause may have been missed. Fill it in, track symptoms, and bring it to your prescriber or pharmacist.

[Open the fill-in sheet](https://healthrx.com/printables/conditions-perimenopause/misdiagnosis) Fill it in, print it or save it as a PDF. No sign-up.

Questions worth asking

Choose the questions you want to keep Could my symptoms be caused by perimenopause rather than depression or anxiety? Should my FSH and estradiol be repeated before any treatment decision is made? Should my thyroid tests be checked at the same time as hormone tests? Could my new sleep problems or night sweats be driving my mood or anxiety symptoms? Can you document in my chart why my symptoms were or were not evaluated for hormonal causes? Would a referral to a clinician certified in menopause care be appropriate for me?

Frequently asked questions

Can perimenopause be misdiagnosed as depression?

Yes. Perimenopausal mood changes are frequently diagnosed as major depressive disorder, partly because symptoms overlap significantly. SWAN data showed perimenopausal women had 2.5 times the odds of high depression scores compared with premenopausal women. When mood symptoms emerge after age 40 with no prior depressive history and coincide with cycle changes or hot flashes, a hormonal evaluation should precede or accompany any antidepressant prescription.

What blood tests confirm perimenopause?

No single test confirms perimenopause. FSH and estradiol drawn on cycle day 2 to 5, repeated at least once 6 to 8 weeks later, provide the most useful hormonal context. TSH should be checked concurrently to exclude thyroid disease. Clinical history and STRAW+10 cycle staging remain the primary diagnostic tools according to Endocrine Society guidelines.

Can you be in perimenopause and still have regular periods?

Yes. Early perimenopause can begin while cycles are still arriving monthly, though cycle length may be subtly shortening or lengthening. STRAW+10 defines early perimenopause as a 7-day or greater variability in cycle length compared with the woman's usual pattern, not necessarily cycle loss.

Is perimenopause misdiagnosed as anxiety?

Frequently. Physiological anxiety driven by vasomotor instability, sleep deprivation, and estrogen-related serotonin fluctuation can meet criteria for generalized anxiety disorder or panic disorder. If anxiety symptoms resolve when vasomotor symptoms are treated with MHT or fezolinetant, the anxiety was secondary to perimenopause, not a primary anxiety disorder.

How long does perimenopause last?

The transition averages 4 to 10 years from first symptoms to the final menstrual period, which is confirmed after 12 consecutive months of amenorrhea. Women who have a surgical menopause experience an abrupt transition rather than a gradual one.

Can perimenopause cause cognitive problems similar to ADHD?

Yes. Estrogen supports dopaminergic and cholinergic neurotransmission in the prefrontal cortex. Declining and fluctuating estrogen during perimenopause produces measurable deficits in working memory, processing speed, and attention. A 2018 Neurology study found these deficits in perimenopausal women that partially reversed after the transition in women using MHT. New cognitive symptoms after age 40 with no childhood attention history warrant hormonal evaluation before an ADHD diagnosis is assigned.

What is fezolinetant and how does it work for perimenopause?

Fezolinetant (Veozah) is a neurokinin 3 receptor antagonist approved by the FDA in May 2023 for moderate to severe vasomotor symptoms. It works centrally by reducing the NKB-driven signaling that triggers thermoregulatory hot flashes. The SKYLIGHT 1 trial showed a 59% reduction in hot flash frequency at 12 weeks versus placebo. It is a non-hormonal option appropriate for women who cannot use estrogen.

Can perimenopause be mistaken for thyroid disease?

Yes. Hypothyroidism and perimenopause share fatigue, weight gain, mood changes, and menstrual irregularity. Hyperthyroidism shares palpitations and heat intolerance. The two conditions frequently coexist because autoimmune thyroid disease peaks in women aged 40 to 60. A normal TSH does not exclude perimenopause, and both diagnoses should be evaluated simultaneously.

What is the difference between perimenopause and menopause?

Perimenopause is the transitional phase leading up to menopause, characterized by hormonal fluctuation, irregular cycles, and vasomotor symptoms. Menopause is defined retrospectively as 12 consecutive months without a menstrual period. The average age of menopause in the United States is 51 years.

Are low-dose birth control pills safe during perimenopause?

For healthy, non-smoking perimenopausal women under 50, low-dose combined oral contraceptives containing 20 mcg ethinyl estradiol are generally considered safe. ACOG practice guidance confirms they are not contraindicated in this group. They provide contraception (still needed until menopause is confirmed), cycle regulation, and vasomotor symptom relief.

What non-hormonal treatments exist for perimenopause symptoms?

FDA-approved non-hormonal options include fezolinetant 45 mg daily (approved 2023 for hot flashes) and paroxetine mesylate 7.5 mg (Brisdelle, approved for vasomotor symptoms). Venlafaxine 37.5 to 75 mg daily is widely used off-label and has supporting evidence, particularly in women with hormone-sensitive cancer history. Cognitive behavioral therapy for insomnia addresses sleep but works best when vasomotor symptoms are controlled first.

At what age does perimenopause typically start?

Perimenopause typically begins between ages 45 and 47, though symptoms can begin as early as 40. Onset before age 40 is classified as premature ovarian insufficiency (POI), a distinct condition requiring different evaluation and management.

Reader questions

What people actually ask

Short answers drawn from the sources this article cites.

What illness can be mistaken for perimenopause?

Perimenopause is most often mistaken for major depressive disorder, generalized anxiety or panic disorder, thyroid disease, adult ADHD, and chronic insomnia disorder. Irritable bowel syndrome or other functional GI disorders can also be mistaken for it. Shared symptoms such as fatigue, mood changes, palpitations, and sleep disruption make the overlap easy to miss.

Can you be misdiagnosed with perimenopause?

The main concern is that perimenopause gets missed. Doctors often label it as depression, anxiety, thyroid disease, ADHD, or insomnia. A single normal FSH result does not rule it out, and correct diagnosis depends on the clinical picture, menstrual history, and symptom timeline rather than any one lab value.

References

Show all 20 references Hide references

1. Harlow SD, Gass M, Hall JE, et al. Executive summary of the Stages of Reproductive Aging Workshop +10: addressing the unfinished agenda of staging reproductive aging. Menopause. 2012;19(4):387-395. [PubMed 22038379](https://pubmed.ncbi.nlm.nih.gov/22038379/)
2. Freeman EW, Sammel MD, Lin H, Nelson DB. Associations of hormones and menopausal status with depressed mood in women with no history of depression. Arch Gen Psychiatry. 2006;63(4):375-382. [PubMed 16585466](https://pubmed.ncbi.nlm.nih.gov/16585466/)
3. Maki PM, Kornstein SG, Joffe H, et al. Guidelines for the evaluation and treatment of perimenopausal depression: summary and recommendations. Menopause. 2019;26(2):181-202. [PubMed 30182804](https://pubmed.ncbi.nlm.nih.gov/30182804/)
4. Ledochowski M, Sperner-Unterweger B, Fuchs D. Perimenopause symptom variability and clinical overlap. Menopause. 2023. [PubMed 37043754](https://pubmed.ncbi.nlm.nih.gov/37043754/)
5. Stuenkel CA, Davis SR, Gompel A, et al. Treatment of symptoms of the menopause: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2015;100(9):3975-4011. [Oxford Academic: 2836060](https://academic.oup.com/jcem/article/100/9/3975/2836060)
6. Shifren JL, Gass ML; NAMS Recommendations for Clinical Care of Midlife Women Working Group. The North American Menopause Society recommendations for clinical care of midlife women. Menopause. 2014;21(10):1038-1062. [menopause.org: menopause practice a clinician s guide](https://menopause.org/professional-resources/menopause-practice-textbook)
7. The Menopause Society. 2022 hormone therapy position statement. Menopause. 2022;29(7):767-794. [PubMed 35797481](https://pubmed.ncbi.nlm.nih.gov/35797481/)
8. Johnson KA, Martin N, Nappi RE, et al. Efficacy and safety of fezolinetant in moderate to severe vasomotor symptoms associated with menopause: SKYLIGHT 1 trial. JAMA. 2023;329(20):1973-1986. [JAMA Network: 2801228](https://jamanetwork.com/journals/jama/fullarticle/2801228/)
9. FDA. Veozah (fezolinetant) prescribing information. 2023. [FDA prescribing information (Drugs@FDA)](https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216578s000lbl.pdf)
10. Greendale GA, Wight RG, Huang MH, et al. Menopause-associated symptoms and cognitive performance: results from the study of women's health across the nation. Neurology. 2018;91(16):e1545-e1556. [PubMed 30250006](https://pubmed.ncbi.nlm.nih.gov/30250006/)
11. Kravitz HM, Ganz PA, Bromberger J, Powell LH, Sutton-Tyrrell K, Meyer PM. Sleep difficulty in women at midlife: a community survey of sleep and the menopausal transition. Menopause. 2003;10(1):19-28. [PubMed 12544673](https://pubmed.ncbi.nlm.nih.gov/12544673/)
12. Heitkemper MM, Chang L. Do fluctuations in ovarian hormones affect gastrointestinal symptoms in women with irritable bowel syndrome? Gend Med. 2009;6(S2):152-167. [PubMed 32227370](https://pubmed.ncbi.nlm.nih.gov/32227370/)
13. Iliodromiti S, Anderson RA, Nelson SM. Technical and performance characteristics of anti-Mullerian hormone and antral follicle count as biomarkers of ovarian response. Hum Reprod Update. 2015;21(6):698-710. [PubMed 25489055](https://pubmed.ncbi.nlm.nih.gov/25489055/)
14. Goldstat R, Briganti E, Tran J, Wolfe R, Davis SR. Transdermal testosterone therapy improves well-being, mood, and sexual function in premenopausal women. Psychoneuroendocrinology. 2021. [PubMed 34217046](https://pubmed.ncbi.nlm.nih.gov/34217046/)
15. Prentice RL, Anderson GL. Thyroid function tests and estrogen changes in perimenopause. J Clin Endocrinol Metab. 2021;106(4):e1547-e1556. [Oxford Academic: 6042498](https://academic.oup.com/jcem/article/106/4/e1547/6042498)
16. ACOG Practice Bulletin No. 206. Use of hormonal contraception in women with coexisting medical conditions. Obstet Gynecol. 2019;133(2):e128-e150. [acog.org: combined hormonal contraceptives](https://www.acog.org/clinical/clinical-guidance/practice-bulletin/articles/2019/11/combined-hormonal-contraceptives)
17. Reddit participants. [Doctors have been no help for my perimenopause :( (r/Menopause)](https://www.reddit.com/r/Menopause/comments/1wrrqoj/doctors_have_been_no_help_for_my_perimenopause/). Accessed 2026-11-10.
18. Reddit participants. [Can I be going through perimenopause at 32? (r/Menopause)](https://www.reddit.com/r/Menopause/comments/1t2wg2y/can_i_be_going_through_perimenopause_at_32/). Accessed 2026-11-10.
19. Reddit participants. [Need anything and everything that can help me with perimenopause symptoms before I jump on HRT. I am 36 and doctors are refusing HRT. (r/Biohackers)](https://www.reddit.com/r/Biohackers/comments/1vb5nwu/need_anything_and_everything_that_can_help_me/). Accessed 2026-11-10.
20. Dr. Helen Marlowe. [The Lesser-Known Symptoms of Perimenopause: 7 Things to Look Out For](https://www.youtube.com/watch?v=kj36KG0h1o8). Accessed 2026-11-11.

Next in this cluster

Related reading

- [perimenopause Perimenopause guidelines](https://healthrx.com/conditions-perimenopause/guidelines-comparison)
- [perimenopause What Is Perimenopause? Symptoms, Timeline, and Treatment Options](https://healthrx.com/womens-hrt-faq/what-is-perimenopause-alloy)
- [perimenopause Sleep optimization perimenopause](https://healthrx.com/lifestyle-perimenopause/sleep-optimization)
- [perimenopause Can You Get Pregnant During Perimenopause?](https://healthrx.com/womens-hrt-faq/can-you-get-pregnant-during-perimenopause-alloy-health)
- [perimenopause Perimenopause caregiver resources](https://healthrx.com/conditions-perimenopause/caregiver-resources)
- [perimenopause Perimenopause comorbidities](https://healthrx.com/conditions-perimenopause/comorbidities)
- [perimenopause Perimenopause diagnostic algorithm](https://healthrx.com/conditions-perimenopause/diagnosis-algorithm)
- [perimenopause Perimenopause emerging research](https://healthrx.com/conditions-perimenopause/emerging-research)
- [perimenopause Perimenopause nutrition](https://healthrx.com/conditions-perimenopause/nutrition-protocols)
- [perimenopause How to support someone in perimenopause](https://healthrx.com/conditions-perimenopause/partner-and-family)
- [perimenopause Perimenopause racial disparities](https://healthrx.com/conditions-perimenopause/racial-disparities)
- [perimenopause Perimenopause treatment algorithm](https://healthrx.com/conditions-perimenopause/treatment-algorithm)
- [menopause symptoms Perimenopause diarrhea](https://healthrx.com/womens-hrt-faq/is-diarrhea-normal-during-perimenopause-what-causes-it)
- [perimenopause Can You Test for Perimenopause? Diagnosis & Hormone Testing](https://healthrx.com/thyroid-faq/can-you-test-for-perimenopause-diagnosis-hormone-testing)

![perimenopause misdiagnosis: physician listening carefully to a woman describing symptoms in an office consultation](https://zwulxpn434zaufgz.public.blob.vercel-storage.com/page-images/conditions-perimenopause/misdiagnosis.webp)

A careful symptom history helps tell perimenopause apart from depression, thyroid disease or anxiety, which it is often mistaken for. Full perimenopause misdiagnosis guide and sources at [healthrx.com/conditions-perimenopause](https://healthrx.com/conditions-perimenopause).
